Documents
Application Sponsors
ANDA 075300 | BEXIMCO PHARMS USA | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Application Products
001 | TABLET;ORAL | 10MG | 0 | LOVASTATIN | LOVASTATIN |
002 | TABLET;ORAL | 20MG | 0 | LOVASTATIN | LOVASTATIN |
003 | TABLET;ORAL | 40MG | 0 | LOVASTATIN | LOVASTATIN |
FDA Submissions
| ORIG | 1 | AP | 2001-12-17 | |
LABELING; Labeling | SUPPL | 2 | AP | 2005-08-18 | |
LABELING; Labeling | SUPPL | 9 | AP | 2017-08-04 | STANDARD |
LABELING; Labeling | SUPPL | 10 | AP | 2020-09-25 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
CDER Filings
BEXIMCO PHARMS USA
cder:Array
(
[0] => Array
(
[ApplNo] => 75300
[companyName] => BEXIMCO PHARMS USA
[docInserts] => ["",""]
[products] => [{"drugName":"LOVASTATIN","activeIngredients":"LOVASTATIN","strength":"10MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LOVASTATIN","activeIngredients":"LOVASTATIN","strength":"20MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"LOVASTATIN","activeIngredients":"LOVASTATIN","strength":"40MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"LOVASTATIN","submission":"LOVASTATIN","actionType":"10MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"LOVASTATIN","submission":"LOVASTATIN","actionType":"20MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"LOVASTATIN","submission":"LOVASTATIN","actionType":"40MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)